Nathan Keller

5.8k total citations
124 papers, 4.0k citations indexed

About

Nathan Keller is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nathan Keller has authored 124 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 40 papers in Infectious Diseases and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nathan Keller's work include Antibiotic Resistance in Bacteria (15 papers), Streptococcal Infections and Treatments (14 papers) and Antimicrobial Resistance in Staphylococcus (13 papers). Nathan Keller is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Streptococcal Infections and Treatments (14 papers) and Antimicrobial Resistance in Staphylococcus (13 papers). Nathan Keller collaborates with scholars based in Israel, United States and Netherlands. Nathan Keller's co-authors include ‪Yasmin Maor‬‏, Juri Kopolovic, Debby Ben-David, Ilana Tal, Gili Regev‐Yochay, Galia Rahav, Ronald N. Jones, Donald E. Low, Ana Tobar and A.L. Barth and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Nathan Keller

116 papers receiving 3.8k citations

Peers

Countries citing papers authored by Nathan Keller

Since Specialization

Citations

This map shows the geographic impact of Nathan Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Keller more than expected).

Fields of papers citing papers by Nathan Keller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Keller. The network helps show where Nathan Keller may publish in the future.

Co-authorship network of co-authors of Nathan Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Keller. A scholar is included among the top collaborators of Nathan Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Keller. Nathan Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical characteristics, outcomes, and subtype diversity in hospitalized human rhinovirus (HRV) patients 2025 ·PLoS ONE ·(unknown), (unknown), Eugene Leibovitz, Nathan Keller, Dafna Yahav, Galia Barkai, (unknown), (unknown), (unknown), Ana Belkin, Yaniv Lustig, Michal Stein, Michal Mandelboim	1
2	Novel Three‐Dimensional Printed Simulators for Ultrasound‐Guided Prenatal Diagnostic Procedures 2025 ·Journal of Ultrasound in Medicine ·Nathan Keller, (unknown), Frank I. Jackson, (unknown), Jolene Muscat, Luis A. Bracero, Matthew J. Blitz	1
3	Presence and Size of Placental Lakes on 20-Week Fetal Anatomy Ultrasound and Obstetrical Outcomes 2024 ·Journal of Obstetrics and Gynaecology Canada ·Nathan Keller, (unknown), Dimitre G. Stefanov, Frank I. Jackson, (unknown), (unknown), (unknown), (unknown), Luis A. Bracero, Matthew J. Blitz	1
4	Epidemiological and clinical characteristics of hospitalized human metapneumovirus patients in Israel, 2015–2021: A retrospective cohort study 2024 ·Journal of Medical Virology ·(unknown), (unknown), Ital Nemet, Nathan Keller, Eugene Leibovitz, (unknown), Or Kriger, Galia Barkai, Michal Mandelboim, Michal Stein	4
5	Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel 2023 ·Journal of Medical Virology ·(unknown), Ital Nemet, (unknown), (unknown), Limor Kliker, (unknown), Nathan Keller, Eugene Leibovitz, Ella Mendelson, Michal Mandelboim, Michal Stein	2
6	Fetal hypertrophic cardiomyopathy with elevated middle cerebral artery peak systolic velocity ( MCA PSV ): A potentially grim association 2023 ·SHILAP Revista de lepidopterología ·Nathan Keller, Luis A. Bracero, (unknown), (unknown), Matthew J. Blitz	1
7	Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing 2018 ·Journal of Visualized Experiments ·Ayelet Di Segni, Tzipi Braun, (unknown), (unknown), Efrat G. Saar, Karen Cesarkas, James E. Squires, Nathan Keller, Yael Haberman	23
8	Fecal microbial characterization of hospitalized patients with suspected infectious diarrhea shows significant dysbiosis 2017 ·Scientific Reports ·Tzipi Braun, Ayelet Di Segni, (unknown), (unknown), James E. Squires, (unknown), Efrat G. Saar, Karen Cesarkas, Gill Smollan, Batia Weiss, Sharon Amit, Nathan Keller, Yael Haberman	27
9	Molecular Detection of Antibiotic Resistance Genes from Positive Blood Cultures 2014 ·Methods in molecular biology ·Musa Hindiyeh, Gill Smollan, Shiraz Gefen-Halevi, Ella Mendelson, Nathan Keller	2
10	Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel 2012 ·Clinical Microbiology and Infection ·Ronen Ben‐Ami, Galia Rahav, Hila Elinav, Imad Kassis, Itamar Shalit, Tamar Gottesman, Orli Megged, Miriam Weinberger, (unknown), Pnina Shitrit, Regina Weber, Alona Paz, Dan Miron, I. Oren, Jihad Bishara, Colin Block, Nathan Keller, Dimitrios P. Kontoyiannis, Michael Giladi	19
11	Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections 2011 ·Clinical Microbiology and Infection ·Debby Ben-David, (unknown), Nathan Keller, Ilana Tal, Alex Marzel, Ohad Gal‐Mor, ‪Yasmin Maor‬‏, G. Rahav	277
12	Bacteremia caused by a highly-resistant Streptococcus pneumoniae serotype 19A circulating in a daycare center 2010 ·International Journal of Infectious Diseases ·Dror S. Shouval, Nurith Porat, Ron Dagan, Nathan Keller, Efraim Bilavsky, (unknown), Jacob Amir	2
13	Related-key boomerang and rectangle attacks 2005 ·Eli Biham, Orr Dunkelman, Nathan Keller	0
14	A Related-Key Rectangle Attack on the Full KASUMI 2005 ·Eli Biham, Orr Dunkelman, Nathan Keller	2
15	Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients 2004 ·European Journal of Clinical Microbiology & Infectious Diseases ·Raul Colodner, Wasseem Rock, Bibiana Chazan, Nathan Keller, (unknown), W. Sakran, Raanan Raz	306
16	Nasopharyngeal Carriage ofStreptococcus pneumoniaeby Adults and Children in Community and Family Settings 2004 ·Clinical Infectious Diseases ·Gili Regev‐Yochay, Meir Raz, Ron Dagan, Nurith Porat, Bracha Shainberg, Erica Pinco, Nathan Keller, Ethan Rubinstein	203
17	Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome 2002 ·Journal of Clinical Investigation ·Miri Blank, Ilan Krause, Mati Fridkin, Nathan Keller, Juri Kopolovic, Iris Goldberg, Ana Tobar, Yehuda Shoenfeld	14
18	The effect of albumin globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli 2000 ·Clinical Microbiology and Infection ·Eric Rubinstein, (unknown), (unknown), (unknown), Bina Rubinovitch, Aviv Barzilai, Nathan Keller	16
19	A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections 1998 ·The Pediatric Infectious Disease Journal ·Ron Dagan, Drora Fraser, (unknown), Nathan Keller, (unknown), Gila Shazberg, Menachem Schlesinger	26
20	The use of porphyrins for eradication ofStaphylococcus aureusin burn wound infections 1997 ·FEMS Immunology & Medical Microbiology ·Arie Orenstein, (unknown), Juri Kopolovic, (unknown), Zvi Malik, Nathan Keller, (unknown)	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact